当前位置: X-MOL 学术Cancer Cell › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.
Cancer Cell ( IF 50.3 ) Pub Date : 2020-05-11 , DOI: 10.1016/j.ccell.2020.04.004
Wendy Béguelin 1 , Matt Teater 2 , Cem Meydan 3 , Kenneth B Hoehn 4 , Jude M Phillip 1 , Alexey A Soshnev 5 , Leandro Venturutti 1 , Martín A Rivas 1 , María T Calvo-Fernández 1 , Johana Gutierrez 1 , Jeannie M Camarillo 6 , Katsuyoshi Takata 7 , Karin Tarte 8 , Neil L Kelleher 6 , Christian Steidl 7 , Christopher E Mason 9 , Olivier Elemento 10 , C David Allis 5 , Steven H Kleinstein 11 , Ari M Melnick 1
Affiliation  

Follicular lymphomas (FLs) are slow-growing, indolent tumors containing extensive follicular dendritic cell (FDC) networks and recurrent EZH2 gain-of-function mutations. Paradoxically, FLs originate from highly proliferative germinal center (GC) B cells with proliferation strictly dependent on interactions with T follicular helper cells. Herein, we show that EZH2 mutations initiate FL by attenuating GC B cell requirement for T cell help and driving slow expansion of GC centrocytes that become enmeshed with and dependent on FDCs. By impairing T cell help, mutant EZH2 prevents induction of proliferative MYC programs. Thus, EZH2 mutation fosters malignant transformation by epigenetically reprograming B cells to form an aberrant immunological niche that reflects characteristic features of human FLs, explaining how indolent tumors arise from GC B cells.

中文翻译:

突变的EZH2通过重新编程免疫应答诱导恶性前淋巴瘤的生态位。

滤泡性淋巴瘤(FLs)是生长缓慢的惰性肿瘤,包含广泛的滤泡性树突状细胞(FDC)网络和复发性EZH2功能获得性突变。矛盾的是,FLs起源于高度增殖的生发中心(GC)B细胞,其增殖严格取决于与T滤泡辅助细胞的相互作用。在本文中,我们显示EZH2突变通过减弱T细胞帮助的GC B细胞需求并驱动缓慢陷入与FDC依赖的GC中心细胞的扩张来启动FL。通过削弱T细胞的帮助,突变体EZH2阻止了增殖性MYC程序的诱导。因此,EZH2突变通过表观遗传重编程B细胞以形成反映人FLs特征的异常免疫位,从而促进恶性转化,从而解释了GC B细胞是如何产生惰性肿瘤的。
更新日期:2020-05-11
down
wechat
bug